Orthofix surges after CMS change on non-invasive bone growth stimulators
· seekingalpha.com
Orthofix Medical jumps 16% after CMS reverses bone growth stimulator reclassification, boosting reimbursement outlook. Read more here.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...